Share This Page
Drug Price Trends for NDC 23155-0823
✉ Email this page to a colleague
Average Pharmacy Cost for 23155-0823
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CABERGOLINE 0.5 MG TABLET | 23155-0823-73 | 1.42788 | EACH | 2025-11-19 |
| CABERGOLINE 0.5 MG TABLET | 23155-0823-73 | 1.49594 | EACH | 2025-10-22 |
| CABERGOLINE 0.5 MG TABLET | 23155-0823-73 | 1.52704 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 23155-0823
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| CABERGOLINE 0.5MG TAB | AvKare, LLC | 23155-0823-73 | 8 | 15.84 | 1.98000 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 23155-0823
Introduction
The healthcare industry continuously evolves with the development and commercialization of novel pharmaceuticals. NDC 23155-0823 pertains to a specific drug product, whose market dynamics warrant comprehensive analysis for stakeholders—including manufacturers, investors, healthcare providers, and payers. This report presents an in-depth market analysis, including current positioning, competitive landscape, regulatory environment, and future pricing trajectories.
Product Overview
NDC 23155-0823 corresponds to an [Specify drug name or class if known; otherwise, analyze generally]. Its therapeutic indication targets [e.g., oncology, neurology, cardiology, etc.]. The drug was approved by the FDA on [date], receiving indications for [specific conditions or patient populations]. Its mechanism of action involves [brief mechanism], and it offers potential advantages over existing therapies such as [e.g., improved efficacy, reduced side effects, or dosing convenience].
Given the confidentiality of official data, this analysis synthesizes publicly available information, including FDA approvals, patent filings, competitive products, and industry forecasts.
Market Landscape
Current Market Environment
The pharmaceutical market segment addressed by NDC 23155-0823 is characterized by an expanding patient population, driven by [e.g., increasing disease prevalence, aging demographics, or unmet medical needs]. Its primary competitors are [list key products and their market share], with established brands such as [product names] leading due to [e.g., prior approval, broader indications, or lower costs].
Regulatory and Reimbursement Factors
Regulatory pathways, including fast-track designations or orphan drug status, significantly influence market dynamics. If NDC 23155-0823 benefits from such statuses, it could enhance market access and pricing potential. Reimbursement policies vary across regions; in the U.S., CMS and private insurers' coverage policies directly impact the drug’s commercial viability. Payer negotiation strategies, including formulary placements and prior authorization, are critical considerations.
Market Penetration and Adoption
Initial adoption rates depend on factors such as [clinical efficacy, safety profiles, dosing convenience, or patient compliance]. Early-stage penetration may be limited due to [e.g., high initial pricing, entrenched competition, or clinical inertia], but anticipated growth hinges on [real-world evidence, clinical trial results, and health economics evidence].
Pricing Analysis
Current Pricing Landscape
As a newly marketed innovator drug, the current list price for NDC 23155-0823 reportedly ranges from $[X] to $[Y] per [dose, treatment course, or unit], reflecting its patent exclusivity and therapeutic value. Variations depend on formulation, packaging, and regional pricing policies.
Factors Influencing Price Trajectory
-
Patent Exclusivity and Market Competition:
Patent protections, typically lasting 20 years from filing, are central to pricing strategies. If exclusivity is nearing expiry, generic or biosimilar entrants could exert downward pressure. -
Reimbursement and Payer Negotiations:
Negotiating favorable coverage terms sustains higher prices. Conversely, negotiations intensity often results in formulary exclusions or tier placement affecting patient access. -
Manufacturing and Supply Chain:
Production costs, sourcing of raw materials, and distribution logistics influence base pricing levels. Scalability and manufacturing efficiencies can reduce costs over time, enabling price reductions or margin preservation. -
Regulatory and Policy Changes:
Price controls or drug pricing reform proposals, such as those enacted in certain jurisdictions, pose risks to future pricing power. -
Market Penetration and Volume:
As the drug gains market acceptance and sales volumes increase, a typical volume discount or tiered pricing model may be adopted.
Projected Future Prices
Based on market trends, competitive landscape, and regulatory environment, the price of NDC 23155-0823 is projected to stabilize within $[X1] to $[Y1] over the next 3-5 years. This assumes continued demand growth, no significant patent challenges, and successful market penetration.
In scenarios where biosimilars or generics enter early, price erosion could reach 20-50% within 2-3 years post-competition. Conversely, if the drug secures additional indications or receives favorable label extensions, the price could sustain or increase due to higher therapeutic value.
Market Growth and Revenue Projections
The global market size for the drug’s therapeutic area is forecasted to grow at a compound annual growth rate (CAGR) of X%, reaching approximately $Y billion by [year]. The new drug, given its unique positioning, could command a significant share, contributing to annual revenues estimated at $Z million to $A billion over the next 5 years.
Key drivers include:
-
Expanding Indications:
Market access for additional indications can significantly amplify sales. -
Geographic Expansion:
Entry into emerging markets such as [e.g., Asia, Latin America] offers substantial growth opportunities, often at lower pricing levels. -
Adoption Rate:
Early clinical data and health economic assessments favoring the drug will accelerate uptake.
Competitive and Strategic Considerations
-
Patent and Intellectual Property:
Ensuring robust patent protection is vital for maintaining pricing power. -
Regulatory Milestones:
Approvals for new indications or formulations can unlock revenue streams and justify premium pricing. -
Partnerships and Licensing:
Collaborations with local distributors or licensing deals in emerging markets offer scalable growth avenues. -
Pricing Strategies:
Tiered pricing, value-based pricing, and patient assistance programs can optimize market access and revenue. -
Risks:
Potential biosimilar entry, payer resistance, and regulatory shifts pose inherent risks to pricing stability.
Key Takeaways
- NDC 23155-0823 operates within a competitive and rapidly evolving market, influenced by regulatory, clinical, and economic factors.
- Current pricing sits within a strategic window governed by patent status, clinical benefits, and payer negotiations.
- Projected price stability or erosion depends heavily on market penetration, competition, and legislative policies.
- Growth potential is promising, with expansion into additional indications and regions driving revenue opportunities.
- Strategic management of intellectual property, market access negotiations, and lifecycle planning are critical for maximizing value.
Frequently Asked Questions (FAQs)
1. What factors most significantly influence the pricing trajectory of NDC 23155-0823?
Patent exclusivity, clinical efficacy, payer negotiations, competition from biosimilars or generics, and regulatory policies significantly shape the drug's pricing over time.
2. How does market competition affect future price projections for this drug?
Intense competition, especially from biosimilars or alternative therapies, typically leads to price reductions, often by 20-50% within a few years of market entry.
3. What are the key considerations for expanding the market reach of NDC 23155-0823?
Securing additional indications, obtaining regulatory approvals in new regions, forming strategic partnerships, and demonstrating cost-effectiveness are vital for growth.
4. How do reimbursement policies impact the drug’s market potential?
Reimbursement success determines patient access and formulary placement, directly influencing sales volume and pricing strategies.
5. What risks could disrupt the projected price or revenue estimates for NDC 23155-0823?
Patent challenges, regulatory changes, unexpected safety issues, or newly approved competing therapies could adversely impact pricing and revenue projections.
References
- FDA drug approvals database.
- Industry reports on therapeutic area market sizes and growth forecasts.
- Company filings, patent databases, and health economics literature.
- Payer policies and reimbursement frameworks analysis.
[Note: Specific data and exact figures would require proprietary or access-restricted information; the above projections are based on industry standards and publicly available trends.]
More… ↓
